학술논문
Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.
Document Type
Article
Author
Chang, Chun Chin; Chichareon, Ply; Modolo, Rodrigo; Takahashi, Kuniaki; Kogame, Norihiro; Tomaniak, Mariusz; Gao, Chao; Royaards, Kees-Jan; Cequier, Angel; Oldroyd, Keith; Steg, Philippe Gabriel; Hamm, Christian; Jüni, Peter; Valgimigli, Marco; Windecker, Stephan; Onuma, Yoshinobu; Stables, Rod H; Jan van Geuns, Robert; Serruys, Patrick W
Source
European Heart Journal - Cardiovasular Pharmacotherapy; January 2020, Vol. 6 Issue: 1 p22-30, 9p
Subject
Language
ISSN
20556837; 20556845
Abstract
The efficacy and safety of continued bivalirudin infusion after percutaneous coronary intervention (PCI) remains uncertain. We sought to investigate the association between post-PCI bivalirudin infusion and the risk of net adverse clinical events (NACE) at 30 days.